Research output

Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Research output: Contribution to journalReview articleAcademicpeer-review

Associated researcher

Associated organisations

    Research areas

  • 1ST-LINE TREATMENT, ENDOCRINE THERAPY, LETROZOLE, BEVACIZUMAB, PALBOCICLIB, UTILITY
View graph of relations

Details

Original languageEnglish
Pages (from-to)141-153
Number of pages13
JournalPharmacoeconomics
Volume37
Issue number2
DOIs
Publication statusPublished - Feb 2019